Estimating The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Zimmer Biomet Holdings fair value estimate is US$149 Current share price of US$120 suggests Zimmer Biomet Holdings is potentially trading clo
Zimmer Biomet Holdings To Go Ex-Dividend On June 26th, 2024 With 0.24 USD Dividend Per Share
May 14th - $Zimmer Biomet Holdings(ZBH.US)$ is trading ex-dividend on June 26th, 2024. Shareholders of record on June 26th, 2024 will receive 0.24 USD dividend per share on July 31st, 2024. The ex
Zimmer Biomet Holdings: A Strong Buy on Robust Performance and Growth Outlook
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Annexon Biosciences (ANNX) and Cytokinetics (CYTK)
Press Release: Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024 PR Newswire WARSAW, Ind., May 13, 2024 WARSAW, Ind., May 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: Z
Top Stock Reports for Amazon.com, Visa & Pfizer
Truist Financial Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings (ZBH) Gets a Buy From Stifel Nicolaus
Analysts Are Bullish on Top Healthcare Stocks: Scholar Rock Holding (SRRK), Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings: A Cautious Hold Rating With Conservative Valuation Ahead of Investor Day
Zimmer Biomet Publishes 2023 Sustainability Report
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today published its 2023 Sustainability Report which provides...
Zimmer Biomet Holdings: A Cautious Hold Amid Competitive Market Challenges and Mixed Financial Results
Analyst Expectations For Zimmer Biomet Holdings's Future
In the last three months, 9 analysts have published ratings on Zimmer Biomet Holdings (NYSE:ZBH), offering a diverse range of perspectives from bullish to bearish.The following table summarizes their
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2024 Earnings Call Transcript
Zimmer Biomet Holdings Price Target Cut to $130.00/Share From $137.00 by Truist Securities
Zimmer Biomet Holdings Price Target Cut to $130.00/Share From $137.00 by Truist Securities
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating
Zimmer Biomet Holdings (ZBH) has an average rating of hold and price targets ranging from $112 to $175, according to analysts polled by Capital IQ. Price: 120.41, Change: +1.95, Percent Change: +1.64
Zimmer Biomet Holdings Is Maintained at Outperform by Oppenheimer
Zimmer Biomet Holdings Is Maintained at Outperform by Oppenheimer
Oppenheimer Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150
Zimmer Biomet Holdings (ZBH) has an average hold rating and a price target range of $109 to $175, according to analysts polled by Capital IQ. Price: 119.30, Change: +0.84, Percent Change: +0.71
Buy Rating on Zimmer Biomet Holdings: Growth Trajectory and Favorable Valuation
No Data